全文获取类型
收费全文 | 1338784篇 |
免费 | 112204篇 |
国内免费 | 6364篇 |
专业分类
耳鼻咽喉 | 16705篇 |
儿科学 | 43007篇 |
妇产科学 | 36559篇 |
基础医学 | 183625篇 |
口腔科学 | 36272篇 |
临床医学 | 120693篇 |
内科学 | 278515篇 |
皮肤病学 | 31890篇 |
神经病学 | 110498篇 |
特种医学 | 55533篇 |
外国民族医学 | 274篇 |
外科学 | 210336篇 |
综合类 | 31527篇 |
现状与发展 | 2篇 |
一般理论 | 414篇 |
预防医学 | 106625篇 |
眼科学 | 28085篇 |
药学 | 93702篇 |
5篇 | |
中国医学 | 2227篇 |
肿瘤学 | 70858篇 |
出版年
2018年 | 13376篇 |
2017年 | 10632篇 |
2016年 | 12796篇 |
2015年 | 14298篇 |
2014年 | 19946篇 |
2013年 | 29734篇 |
2012年 | 36237篇 |
2011年 | 38885篇 |
2010年 | 24370篇 |
2009年 | 23903篇 |
2008年 | 36359篇 |
2007年 | 38775篇 |
2006年 | 39901篇 |
2005年 | 38490篇 |
2004年 | 36724篇 |
2003年 | 35820篇 |
2002年 | 33834篇 |
2001年 | 66054篇 |
2000年 | 67919篇 |
1999年 | 56588篇 |
1998年 | 16723篇 |
1997年 | 15017篇 |
1996年 | 16014篇 |
1995年 | 16232篇 |
1994年 | 15098篇 |
1993年 | 14153篇 |
1992年 | 47100篇 |
1991年 | 45749篇 |
1990年 | 43970篇 |
1989年 | 41815篇 |
1988年 | 38758篇 |
1987年 | 38081篇 |
1986年 | 35860篇 |
1985年 | 34636篇 |
1984年 | 26358篇 |
1983年 | 22108篇 |
1982年 | 13847篇 |
1981年 | 12447篇 |
1980年 | 11718篇 |
1979年 | 23544篇 |
1978年 | 17072篇 |
1977年 | 14385篇 |
1976年 | 13182篇 |
1975年 | 13722篇 |
1974年 | 16093篇 |
1973年 | 15396篇 |
1972年 | 14173篇 |
1971年 | 13038篇 |
1970年 | 11881篇 |
1969年 | 11101篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
Jenny U. Johansson Nathaniel S. Woodling Qian Wang Maharshi Panchal Xibin Liang Angel Trueba-Saiz Holden D. Brown Siddhita D. Mhatre Taylor Loui Katrin I. Andreasson 《The Journal of clinical investigation》2015,125(1):350-364
Microglia, the innate immune cells of the CNS, perform critical inflammatory and noninflammatory functions that maintain normal neural function. For example, microglia clear misfolded proteins, elaborate trophic factors, and regulate and terminate toxic inflammation. In Alzheimer’s disease (AD), however, beneficial microglial functions become impaired, accelerating synaptic and neuronal loss. Better understanding of the molecular mechanisms that contribute to microglial dysfunction is an important objective for identifying potential strategies to delay progression to AD. The inflammatory cyclooxygenase/prostaglandin E2 (COX/PGE2) pathway has been implicated in preclinical AD development, both in human epidemiology studies and in transgenic rodent models of AD. Here, we evaluated murine models that recapitulate microglial responses to Aβ peptides and determined that microglia-specific deletion of the gene encoding the PGE2 receptor EP2 restores microglial chemotaxis and Aβ clearance, suppresses toxic inflammation, increases cytoprotective insulin-like growth factor 1 (IGF1) signaling, and prevents synaptic injury and memory deficits. Our findings indicate that EP2 signaling suppresses beneficial microglia functions that falter during AD development and suggest that inhibition of the COX/PGE2/EP2 immune pathway has potential as a strategy to restore healthy microglial function and prevent progression to AD. 相似文献
92.
93.
More than just crushing: a prospective pre‐post intervention study to reduce drug preparation errors in patients with feeding tubes
下载免费PDF全文
![点击此处可从《Journal of clinical pharmacy and therapeutics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
94.
95.
96.
97.
98.
99.
L. Misery E. Weisshaar E. Brenaut A.W.M. Evers F. Huet S. Ständer A. Reich E. Berardesca E. Serra-Baldrich J. Wallengren D. Linder J.W. Fluhr J.C. Szepietowski H. Maibach for the Special Interest Group on sensitive skin of the International Forum for the Study of Itch 《Journal of the European Academy of Dermatology and Venereology》2020,34(2):222-229
The special interest group on sensitive skin of the International Forum for the Study of Itch previously defined sensitive skin as a syndrome defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus and tingling sensations) in response to stimuli that normally should not provoke such sensations. This additional paper focuses on the pathophysiology and the management of sensitive skin. Sensitive skin is not an immunological disorder but is related to alterations of the skin nervous system. Skin barrier abnormalities are frequently associated, but there is no cause and direct relationship. Further studies are needed to better understand the pathophysiology of sensitive skin – as well as the inducing factors. Avoidance of possible triggering factors and the use of well-tolerated cosmetics, especially those containing inhibitors of unpleasant sensations, might be suggested for patients with sensitive skin. The role of psychosocial factors, such as stress or negative expectations, might be relevant for subgroups of patients. To date, there is no clinical trial supporting the use of topical or systemic drugs in sensitive skin. The published data are not sufficient to reach a consensus on sensitive skin management. In general, patients with sensitive skin require a personalized approach, taking into account various biomedical, neural and psychosocial factors affecting sensitive skin. 相似文献